Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2021 Volume 21 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2021 Volume 21 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Diammonium glycyrrhizinate lipid ligand ameliorates lipopolysaccharide‑induced acute lung injury by modulating vascular endothelial barrier function

  • Authors:
    • Mei-Mei Liu
    • Jin Zhou
    • Dan Ji
    • Jun Yang
    • Yan-Ping Huang
    • Qi Wang
  • View Affiliations / Copyright

    Affiliations: Department of Histology and Embryology, Anhui Medical College, Hefei, Anhui 230601, P.R. China
    Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 303
    |
    Published online on: January 29, 2021
       https://doi.org/10.3892/etm.2021.9734
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to investigate the effects of diammonium glycyrrhizinate lipid ligand (DGLL) treatment on acute lung injury (ALI) and pulmonary edema induced by lipopolysaccharide (LPS) in Sprague‑Dawley rats. Rats orally received 30, 60 and 120 mg/kg DGLL. After 1 h, the rat ALI model was established by LPS (10 mg/kg) intraperitoneal injection. After 6 h, lung injury was evaluated using hematoxylin and eosin staining techniques. Pulmonary edema was evaluated using lung wet‑dry weight ratio, protein concentrations in the bronchoalveolar lavage fluid (BALF) and Evans blue (EB) extravasation in lung tissue. The expression levels of tumor necrosis factor (TNF)‑α and interleukin (IL)‑1β in lung tissues were measured using ELISA. Myeloperoxidase (MPO) expression levels were detected by immunohistochemical staining. Western blotting was used to measure the expression level changes of intercellular adhesion molecule (ICAM)‑1, as well as adherent and tight junction proteins, including vascular endothelial (VE)‑cadherin, zonula occludens (ZO)‑1, occludin and junctional adhesion molecule (JAM)‑1 that were associated with pulmonary inflammation and microvascular permeability. DGLL treatment significantly alleviated ALI induced by LPS, which was demonstrated by reduction of MPO‑positive cells and expression levels of TNF‑α, IL‑1β and ICAM‑1 in rat lung tissues. In addition, DGLL abrogated LPS‑induced pulmonary edema, decreased the protein concentration in BALF and reduced EB extravasation. DGLL also reversed the reduced expression of VE‑cadherin and tight junction proteins, including ZO‑1, occludin and JAM‑1 in the lung tissues caused by LPS. In conclusion, DGLL exhibits a protective effect on LPS‑induced rat ALI, which is associated with the inhibition of inflammatory cell infiltration and microvascular barrier disruption. The present results provide a theoretical basis for the application of DGLL for the potential clinical treatment of ALI.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Piantadosi CA and Schwartz DA: The acute respiratory distress syndrome. Ann Intern Med. 141:460–470. 2004.PubMed/NCBI View Article : Google Scholar

2 

Rezoagli E, Fumagalli R and Bellani G: Definition and epidemiology of acute respiratory distress syndrome. Ann Transl Med. 5(282)2017.PubMed/NCBI View Article : Google Scholar

3 

Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, et al: LUNG SAFE Investigators; ESICM Trials Group: Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 315:788–800. 2016.PubMed/NCBI View Article : Google Scholar

4 

Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M and Umberger R: Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest. 131:954–963. 2007.PubMed/NCBI View Article : Google Scholar

5 

Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T and Tolley EA: Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial. JAMA. 280:159–165. 1998.PubMed/NCBI View Article : Google Scholar

6 

Matthay MA, Ware LB and Zimmerman GA: The acute respiratory distress syndrome. J Clin Invest. 122:2731–2740. 2012.PubMed/NCBI View Article : Google Scholar

7 

Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, Randolph AG and Calfee CS: Acute respiratory distress syndrome. Nat Rev Dis Primers. 5(18)2019.PubMed/NCBI View Article : Google Scholar

8 

Fan E, Brodie D and Slutsky AS: Acute respiratory distress syndrome: Advances in diagnosis and treatment. JAMA. 319:698–710. 2018.PubMed/NCBI View Article : Google Scholar

9 

Matthay MA and Zimmerman GA: Acute lung injury and the acute respiratory distress syndrome: Four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol. 33:319–327. 2005.PubMed/NCBI View Article : Google Scholar

10 

Cardinal-Fernández P, Bajwa EK, Dominguez-Calvo A, Menéndez JM, Papazian L and Thompson BT: The presence of diffuse alveolar damage on open lung biopsy is associated with mortality in patients with acute respiratory distress syndrome: A systematic review and meta-analysis. Chest. 149:1155–1164. 2016.PubMed/NCBI View Article : Google Scholar

11 

Johnson ER and Matthay MA: Acute lung injury: Epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv. 23:243–252. 2010.PubMed/NCBI View Article : Google Scholar

12 

Zhang R, Cheng K, Xu S, Li S, Zhou Y, Zhou S, Kong R, Li L, Li J, Feng J, et al: Metformin and diammonium glycyrrhizinate enteric-coated capsule versus metformin alone versus diammonium glycyrrhizinate enteric-coated capsule alone in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus. Gastroenterol Res Pract. 2017(8491742)2017.PubMed/NCBI View Article : Google Scholar

13 

Pang H, Huang T, Song J, Li D, Zhao Y and Ma X: Inhibiting HMGB1 with glycyrrhizic acid protects brain injury after DAI via its anti-inflammatory effect. Mediators Inflamm. 2016(4569521)2016.PubMed/NCBI View Article : Google Scholar

14 

Cai Y, Xu Y, Chan HF, Fang X, He C and Chen M: Glycyrrhetinic acid mediated drug delivery carriers for hepatocellular carcinoma therapy. Mol Pharm. 13:699–709. 2016.PubMed/NCBI View Article : Google Scholar

15 

He Y, Lou X, Jin Z, Yu L, Deng L and Wan H: Mahuang decoction mitigates airway inflammation and regulates IL-21/STAT3 signaling pathway in rat asthma model. J Ethnopharmacol. 224:373–380. 2018.PubMed/NCBI View Article : Google Scholar

16 

Zhong Y, Zhou J, Liang N, Liu B, Lu R, He Y, Liang C, Wu J, Zhou Y, Hu M, et al: Effect of maxing Shigan Tang on H1N1 influenza a virus-associated acute lung injury in mice. Intervirology. 59:267–274. 2016.PubMed/NCBI View Article : Google Scholar

17 

Yao L and Sun T: Glycyrrhizin administration ameliorates Streptococcus aureus-induced acute lung injury. Int Immunopharmacol. 70:504–511. 2019.PubMed/NCBI View Article : Google Scholar

18 

Chen J, Zhang W, Zhang L, Zhang J, Chen X, Yang M, Chen T and Hong J: Glycyrrhetinic acid alleviates radiation-induced lung injury in mice. J Radiat Res (Tokyo). 58:41–47. 2017.PubMed/NCBI View Article : Google Scholar

19 

Zhang D, Liu B, Cao B, Wei F, Yu X, Li GF, Chen H, Wei LQ and Wang PL: Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4. Int Immunopharmacol. 48:67–75. 2017.PubMed/NCBI View Article : Google Scholar

20 

Jung JC, Lee YH, Kim SH, Kim KJ, Kim KM, Oh S and Jung YS: Hepatoprotective effect of licorice, the root of Glycyrrhiza uralensis Fischer, in alcohol-induced fatty liver disease. BMC Complement Altern Med. 16(19)2016.PubMed/NCBI View Article : Google Scholar

21 

Tsuruoka N, Abe K, Wake K, Takata M, Hatta A, Sato T and Inoue H: Hepatic protection by glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in mice. Inflamm Res. 58:593–599. 2009.PubMed/NCBI View Article : Google Scholar

22 

Kan C, Ding N, Yang J, Tan Z, McGuire TL, Lu H, Zhang K, Berger DM, Kessler JA and Kan L: BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification. Stem Cell Res Ther. 10(14)2019.PubMed/NCBI View Article : Google Scholar

23 

Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS and Kuebler WM: Acute Lung Injury in Animals Study Group. An official American Thoracic Society workshop report: Features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 44:725–738. 2011.PubMed/NCBI View Article : Google Scholar

24 

Chan YH, Harith HH, Israf DA and Tham CL: Differential regulation of LPS-mediated VE-cadherin disruption in human endothelial cells and the underlying signaling pathways: A mini review. Front Cell Dev Biol. 7(280)2020.PubMed/NCBI View Article : Google Scholar

25 

Dong W, He B, Qian H, Liu Q, Wang D, Li J, Wei Z, Wang Z, Xu Z, Wu G, et al: RAB26-dependent autophagy protects adherens junctional integrity in acute lung injury. Autophagy. 14:1677–1692. 2018.PubMed/NCBI View Article : Google Scholar

26 

Audard J, Godet T, Blondonnet R, Joffredo JB, Paquette B, Belville C, Lavergne M, Gross C, Pasteur J, Bouvier D, et al: Inhibition of the receptor for advanced glycation end-products in acute respiratory distress syndrome: A randomised laboratory trial in piglets. Sci Rep. 9(9227)2019.PubMed/NCBI View Article : Google Scholar

27 

Chen H, Bai C and Wang X: The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med. 4:773–783. 2010.PubMed/NCBI View Article : Google Scholar

28 

Cheng KT, Xiong S, Ye Z, Hong Z, Di A, Tsang KM, Gao X, An S, Mittal M, Vogel SM, et al: Caspase-11-mediated endothelial pyroptosis underlies endotoxemia-induced lung injury. J Clin Invest. 127:4124–4135. 2017.PubMed/NCBI View Article : Google Scholar

29 

Tong W, Chen X, Song X, Chen Y, Jia R, Zou Y, Li L, Yin L, He C, Liang X, et al: Resveratrol inhibits LPS-induced inflammation through suppressing the signaling cascades of TLR4-NF-κB/MAPKs/IRF3. Exp Ther Med. 19:1824–1834. 2020.PubMed/NCBI View Article : Google Scholar

30 

Lee YM, Hybertson BM, Cho HG, Terada LS, Cho O, Repine AJ and Repine JE: Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally. Am J Physiol Lung Cell Mol Physiol. 279:L75–L80. 2000.PubMed/NCBI View Article : Google Scholar

31 

Zemans RL, Colgan SP and Downey GP: Transepithelial migration of neutrophils: Mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol. 40:519–535. 2009.PubMed/NCBI View Article : Google Scholar

32 

Abraham E: Neutrophils and acute lung injury. Crit Care Med. 31 (Suppl 4):S195–S199. 2003.PubMed/NCBI View Article : Google Scholar

33 

Feng C, Wang H, Yao C, Zhang J and Tian Z: Diammonium glycyrrhizinate, a component of traditional Chinese medicine Gan-Cao, prevents murine T-cell-mediated fulminant hepatitis in IL-10- and IL-6-dependent manners. Int Immunopharmacol. 7:1292–1298. 2007.PubMed/NCBI View Article : Google Scholar

34 

Jin J, Xiong T, Hou X, Sun X, Liao J, Huang Z, Huang M and Zhao Z: Role of Nrf2 activation and NF-κB inhibition in valproic acid induced hepatotoxicity and in diammonium glycyrrhizinate induced protection in mice. Food Chem Toxicol. 73:95–104. 2014.PubMed/NCBI View Article : Google Scholar

35 

Ding D, Xu S, Zhang H, Zhao W, Zhang X, Jiang Y, Wang P, Dai Z and Zhang J: 3-Methyladenine and dexmedetomidine reverse lipopolysaccharide-induced acute lung injury through the inhibition of inflammation and autophagy. Exp Ther Med. 15:3516–3522. 2018.PubMed/NCBI View Article : Google Scholar

36 

Dreymueller D, Martin C, Kogel T, Pruessmeyer J, Hess FM, Horiuchi K, Uhlig S and Ludwig A: Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide. EMBO Mol Med. 4:412–423. 2012.PubMed/NCBI View Article : Google Scholar

37 

Veszelka S, Pásztói M, Farkas AE, Krizbai I, Ngo TK, Niwa M, Abrahám CS and Deli MA: Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages. Neurochem Int. 50:219–228. 2007.PubMed/NCBI View Article : Google Scholar

38 

Mehta D and Malik AB: Signaling mechanisms regulating endothelial permeability. Physiol Rev. 86:279–367. 2006.PubMed/NCBI View Article : Google Scholar

39 

Rimm DL, Koslov ER, Kebriaei P, Cianci CD and Morrow JS: Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci USA. 92:8813–8817. 1995.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu M, Zhou J, Ji D, Yang J, Huang Y and Wang Q: Diammonium glycyrrhizinate lipid ligand ameliorates lipopolysaccharide‑induced acute lung injury by modulating vascular endothelial barrier function. Exp Ther Med 21: 303, 2021.
APA
Liu, M., Zhou, J., Ji, D., Yang, J., Huang, Y., & Wang, Q. (2021). Diammonium glycyrrhizinate lipid ligand ameliorates lipopolysaccharide‑induced acute lung injury by modulating vascular endothelial barrier function. Experimental and Therapeutic Medicine, 21, 303. https://doi.org/10.3892/etm.2021.9734
MLA
Liu, M., Zhou, J., Ji, D., Yang, J., Huang, Y., Wang, Q."Diammonium glycyrrhizinate lipid ligand ameliorates lipopolysaccharide‑induced acute lung injury by modulating vascular endothelial barrier function". Experimental and Therapeutic Medicine 21.4 (2021): 303.
Chicago
Liu, M., Zhou, J., Ji, D., Yang, J., Huang, Y., Wang, Q."Diammonium glycyrrhizinate lipid ligand ameliorates lipopolysaccharide‑induced acute lung injury by modulating vascular endothelial barrier function". Experimental and Therapeutic Medicine 21, no. 4 (2021): 303. https://doi.org/10.3892/etm.2021.9734
Copy and paste a formatted citation
x
Spandidos Publications style
Liu M, Zhou J, Ji D, Yang J, Huang Y and Wang Q: Diammonium glycyrrhizinate lipid ligand ameliorates lipopolysaccharide‑induced acute lung injury by modulating vascular endothelial barrier function. Exp Ther Med 21: 303, 2021.
APA
Liu, M., Zhou, J., Ji, D., Yang, J., Huang, Y., & Wang, Q. (2021). Diammonium glycyrrhizinate lipid ligand ameliorates lipopolysaccharide‑induced acute lung injury by modulating vascular endothelial barrier function. Experimental and Therapeutic Medicine, 21, 303. https://doi.org/10.3892/etm.2021.9734
MLA
Liu, M., Zhou, J., Ji, D., Yang, J., Huang, Y., Wang, Q."Diammonium glycyrrhizinate lipid ligand ameliorates lipopolysaccharide‑induced acute lung injury by modulating vascular endothelial barrier function". Experimental and Therapeutic Medicine 21.4 (2021): 303.
Chicago
Liu, M., Zhou, J., Ji, D., Yang, J., Huang, Y., Wang, Q."Diammonium glycyrrhizinate lipid ligand ameliorates lipopolysaccharide‑induced acute lung injury by modulating vascular endothelial barrier function". Experimental and Therapeutic Medicine 21, no. 4 (2021): 303. https://doi.org/10.3892/etm.2021.9734
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team